Bouxsein, Mary L <br/><br/>
Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.  [electronic resource] 

 -  The Journal of bone and joint surgery. American volume  Jun 2009 
 - 1329-38 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1535-1386 
<br/><br/><label>Standard No.: </label>10.2106/JBJS.H.01030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Fractures, Spontaneous--drug therapy<br/>Humans<br/>Incidence<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--complications<br/>Prospective Studies<br/>Raloxifene Hydrochloride--therapeutic use<br/>Reference Values<br/>Risk Assessment<br/>Severity of Illness Index<br/>Spinal Fractures--drug therapy<br/>Teriparatide--therapeutic use<br/>Treatment Outcome